Clinical study on Cargill’s Barliv(TM) Barley Beta-Glucan to be presented at American Diabetes Association’s 66th Scientific Sessions

Clinical study on Cargill’s Barliv(TM) Barley Beta-Glucan to be presented at American Diabetes Association’s 66th Scientific Sessions Double blind study results, presented at the American Diabetes Association’s 66th Scientific Sessions, indicate that adding barley beta-glucan to the diet can significantly improve multiple CVD risk markers, and after-meal metabolism among individuals with the metabolic syndrome.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales PacificHealth Laboratories Reports Recent Research Results Investigators from James Madison University presented their findings at the 53rd Annual Meeting of the American College of Sports Medicine indicating that Accelerade improves parameters of exercise performance and decreases muscle fatigue, improves exercise endurance by 19%, decreases muscle damage by 75% and improves muscle functioning measured 24 hours later by 16% and in NCAA Division I cross-country runners, Accelerade reduces muscle damage by 27% and decreases muscle soreness by 30% compared to a carbohydrate-only sports drink. Chrysantis Comments on Latest Eye Health Studies presented at ARVO 10,250 people attended the Association for Research in Vision and Ophthalmology (ARVO) annual conference earlier this month, learning that zeaxanthin supplementation to diabetic rats inhibited the increase in retinal oxidative stress and nutritive stress that is associated with the pathogenesis of retinopathy in diabetics. Chrysantis Comments on Latest Eye Health Studies presented at ARVO 10,250 people attended the Association for Research in Vision and Ophthalmology (ARVO) annual conference earlier this month, learning that zeaxanthin supplementation to diabetic rats inhibited the increase in retinal oxidative stress and nutritive stress that is associated with the pathogenesis of retinopathy in diabetics. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Fish Oil Holds Promise for Those with Type II Diabetes Findings reported by scientists from Texas A&M University-Kingsville suggest that fish oil improves glucose uptake in muscle cells, and that this action is influenced by the concentration of fish oil. Fish Oil Holds Promise for Those with Type II Diabetes Findings reported by scientists from Texas A&M University-Kingsville suggest that fish oil improves glucose uptake in muscle cells, and that this action is influenced by the concentration of fish oil. Fish Oil Holds Promise for Those with Type II Diabetes Findings reported by scientists from Texas A&M University-Kingsville suggest that fish oil improves glucose uptake in muscle cells, and that this action is influenced by the concentration of fish oil. Fish Oil Holds Promise for Those with Type II Diabetes Findings reported by scientists from Texas A&M University-Kingsville suggest that fish oil improves glucose uptake in muscle cells, and that this action is influenced by the concentration of fish oil. Fish Oil Holds Promise for Those with Type II Diabetes Findings reported by scientists from Texas A&M University-Kingsville suggest that fish oil improves glucose uptake in muscle cells, and that this action is influenced by the concentration of fish oil. New Research Backs Role of Dietary Lignans Intake in Breast Health Study measuring enterolactone and genistein levels in 220 premenopausal women and 237 age-matched controls, reported in In the June 2006 issue of the European Journal of Cancer Prevention suggests that there is a decrease in pre-menopausal breast cancer risk in tandem with increased concentrations of plasma enterolactone and no such significant association noted with genistein. New Research Backs Role of Dietary Lignans Intake in Breast Health Study measuring enterolactone and genistein levels in 220 premenopausal women and 237 age-matched controls, reported in In the June 2006 issue of the European Journal of Cancer Prevention suggests that there is a decrease in pre-menopausal breast cancer risk in tandem with increased concentrations of plasma enterolactone and no such significant association noted with genistein. New Research Backs Role of Dietary Lignans Intake in Breast Health Study measuring enterolactone and genistein levels in 220 premenopausal women and 237 age-matched controls, reported in In the June 2006 issue of the European Journal of Cancer Prevention suggests that there is a decrease in pre-menopausal breast cancer risk in tandem with increased concentrations of plasma enterolactone and no such significant association noted with genistein. New Research Backs Role of Dietary Lignans Intake in Breast Health Study measuring enterolactone and genistein levels in 220 premenopausal women and 237 age-matched controls, reported in In the June 2006 issue of the European Journal of Cancer Prevention suggests that there is a decrease in pre-menopausal breast cancer risk in tandem with increased concentrations of plasma enterolactone and no such significant association noted with genistein. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. New Clinical Trial Demonstrates Diachrome(R) Safely Lowers Blood Sugar Levels in People with Type 2 Diabetes Study, presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions, describes an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multi-center study that evaluated 368 subjects taking daily Diachrome supplementation, (which showed a 0.53% average drop in HbA1c), noting a further average decrease of 0.96% HbA1c in the longer term study. New Clinical Trial Demonstrates Diachrome(R) Safely Lowers Blood Sugar Levels in People with Type 2 Diabetes Study, presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions, describes an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multi-center study that evaluated 368 subjects taking daily Diachrome supplementation, (which showed a 0.53% average drop in HbA1c), noting a further average decrease of 0.96% HbA1c in the longer term study. New Clinical Trial Demonstrates Diachrome(R) Safely Lowers Blood Sugar Levels in People with Type 2 Diabetes Study, presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions, describes an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multi-center study that evaluated 368 subjects taking daily Diachrome supplementation, (which showed a 0.53% average drop in HbA1c), noting a further average decrease of 0.96% HbA1c in the longer term study. Acupuncture relieves symptoms of fibromyalgia, Mayo Clinic study finds Mayo Clinic study involving 50 fibromyalgia patients enrolled in a randomized, controlled trial to determine if acupuncture improved their symptoms indicates that symptoms of those who received acupuncture significantly improved compared with the control group. Acupuncture relieves symptoms of fibromyalgia, Mayo Clinic study finds Mayo Clinic study involving 50 fibromyalgia patients enrolled in a randomized, controlled trial to determine if acupuncture improved their symptoms indicates that symptoms of those who received acupuncture significantly improved compared with the control group. Acupuncture relieves symptoms of fibromyalgia, Mayo Clinic study finds Mayo Clinic study involving 50 fibromyalgia patients enrolled in a randomized, controlled trial to determine if acupuncture improved their symptoms indicates that symptoms of those who received acupuncture significantly improved compared with the control group. Acupuncture relieves symptoms of fibromyalgia, Mayo Clinic study finds Mayo Clinic study involving 50 fibromyalgia patients enrolled in a randomized, controlled trial to determine if acupuncture improved their symptoms indicates that symptoms of those who received acupuncture significantly improved compared with the control group. New Research Indicates That Natural Pine Bark Extract Relieves Muscle Cramp And Pain Two studies, with a total of 113 participants indicate that Pycnogenol significantly reduces muscular pain and cramps in athletes and healthy, normal individuals. New Research Indicates That Natural Pine Bark Extract Relieves Muscle Cramp And Pain Two studies, with a total of 113 participants indicate that Pycnogenol significantly reduces muscular pain and cramps in athletes and healthy, normal individuals. New Research Indicates That Natural Pine Bark Extract Relieves Muscle Cramp And Pain Two studies, with a total of 113 participants indicate that Pycnogenol significantly reduces muscular pain and cramps in athletes and healthy, normal individuals. New Research Indicates That Natural Pine Bark Extract Relieves Muscle Cramp And Pain Two studies, with a total of 113 participants indicate that Pycnogenol significantly reduces muscular pain and cramps in athletes and healthy, normal individuals. Triarco Clinical Trial Indicates Aminogen® Boosts Branched-Chain Amino Acids Over 250% Triarco Clinical Trial Indicates Aminogen® Boosts Branched-Chain Amino Acids Over 250% Triarco Clinical Trial Indicates Aminogen® Boosts Branched-Chain Amino Acids Over 250% Triarco Clinical Trial Indicates Aminogen® Boosts Branched-Chain Amino Acids Over 250% Triarco Clinical Trial Indicates Aminogen® Increases Nitrogen Retention By 32%! Triarco clinical trial studied Aminogen’s impact on nitrogen balance, in subjects taking the patented enzyme formula with their whey protein. Nitrogen excretion and retention levels were measured every 4 hours over a 24-hour period. Triarco Clinical Trial Indicates Aminogen® Increases Nitrogen Retention By 32%! Triarco clinical trial studied Aminogen’s impact on nitrogen balance, in subjects taking the patented enzyme formula with their whey protein. Nitrogen excretion and retention levels were measured every 4 hours over a 24-hour period. Triarco Clinical Trial Indicates Aminogen® Increases Nitrogen Retention By 32%! Triarco clinical trial studied Aminogen’s impact on nitrogen balance, in subjects taking the patented enzyme formula with their whey protein. Nitrogen excretion and retention levels were measured every 4 hours over a 24-hour period. Triarco Clinical Trial Indicates Aminogen® Increases Nitrogen Retention By 32%! Triarco clinical trial studied Aminogen’s impact on nitrogen balance, in subjects taking the patented enzyme formula with their whey protein. Nitrogen excretion and retention levels were measured every 4 hours over a 24-hour period. New Study: Pine Bark Extract Reduces ADHD Symptoms In Children New randomized, double-blind placebo-controlled study to be published in the June 17 edition of the journal of European Child & Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol® (1 mg of Pycnogenol or placebo for every kilogram of body weight) for one month. New Study: Pine Bark Extract Reduces ADHD Symptoms In Children New randomized, double-blind placebo-controlled study to be published in the June 17 edition of the journal of European Child & Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol® (1 mg of Pycnogenol or placebo for every kilogram of body weight) for one month. New Study: Pine Bark Extract Reduces ADHD Symptoms In Children New randomized, double-blind placebo-controlled study to be published in the June 17 edition of the journal of European Child & Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol® (1 mg of Pycnogenol or placebo for every kilogram of body weight) for one month. New Study: Pine Bark Extract Reduces ADHD Symptoms In Children New randomized, double-blind placebo-controlled study to be published in the June 17 edition of the journal of European Child & Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol® (1 mg of Pycnogenol or placebo for every kilogram of body weight) for one month. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. Meta-Analysis Confirms Venaforce Horse Chestnut Extract To Be Effective for CVI Study appeared in the journal, Advances in Therapy, Jan/Feb, 2006 - shown in meta-analysis of five studies to be effective in reducing the symptoms associated with chronic venous insufficiency, such as lower leg swelling. Meta-Analysis Confirms Venaforce Horse Chestnut Extract To Be Effective for CVI Study appeared in the journal, Advances in Therapy, Jan/Feb, 2006 - shown in meta-analysis of five studies to be effective in reducing the symptoms associated with chronic venous insufficiency, such as lower leg swelling. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Web Site Detailing Zeaxanthin Science Adds New Pola Group Study Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group. Web Site Detailing Zeaxanthin Science Adds New Pola Group Study Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group. Web Site Detailing Zeaxanthin Science Adds New Pola Group Study Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group. Web Site Detailing Zeaxanthin Science Adds New Pola Group Study Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	MINNEAPOLIS – Results of a Cargill-sponsored clinical study to determine the effects of extracted Barliv™ barley beta-glucan on biomarkers of metabolic syndrome will be presented at the American Diabetes Association’s 66th Scientific Sessions, June 9-13, 2006 in Washington, D.C. The study also will be published in the Scientific Sessions Abstract Book, the June supplement to The Journal of Diabetes. Cargill’s barley beta-glucan concentrate was used in this study. The presentation, Barley Beta-Glucan Concentrate Improves Metabolic Control, Blood Lipids, and Other CVD Biomarkers in a Metabolic Syndrome Population, will be presented by Joel J. Pins, director of the Hypertension and Cholesterol Research Clinic at the University of Minnesota Medical School. Metabolic syndrome is a group of risk factors, including: · Abdominal obesity – a waist circumference over 102 centimeters (40 inches) in men and over 88 centimeters (35 inches) in women) · Elevated serum triglycerides – 150 mg/dL (milligrams of cholesterol per decileter of blood) or above · Low HDL (good) cholesterol – 40mg/dL or lower in men and 50mg/dL or lower in women) · Blood pressure of 130/85 or higher · Elevated fasting blood glucose – 110 mg/dL or above (some groups say 100mg/dL). Presence of at least three of these conditions in an individual is associated with an increased risk of cardiovascular disease (CVD), type 2 diabetes and other chronic diseases. The American Heart Association estimates that more than 50 million Americans have metabolic syndrome. In the double blind study, which was conducted at the University of Minnesota, 155 generally healthy adults with LDL cholesterol levels between 130 and 190 mg/dL, and half of whom met the criteria for metabolic syndrome, followed a low saturated fat, low cholesterol diet for four weeks. Then they consumed ready-to-eat cereal and a juice drink containing barley beta-glucan twice daily for six weeks, while they continued on the diet. The test subjects’ daily intake of barley beta-glucan was either 3 grams or 5 grams. Blood tests confirmed that subjects’ blood levels of glucose and free fatty acids improved after meals among individuals with the metabolic syndrome. The findings indicate that adding barley beta-glucan to the diet can significantly improve multiple CVD risk markers, and after-meal metabolism among individuals with the metabolic syndrome. Cargill’s Barliv™ barley beta-glucan (barley betafiber) is a concentrated soluble fiber derived from barley and has been the subject of several studies. The clinical data show that it has cholesterol-lowering properties similar to oats. ### Cargill is an international provider of food, agricultural and risk management products and services. With 142,000 employees in 61 countries, the company is committed to using its knowledge and experience to collaborate with customers to help them succeed. For more information, visit http://www.cargill.com.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software